Analysts Set Vitalhub Corp. (TSE:VHI) Price Target at C$10.05

Vitalhub Corp. (TSE:VHI) has received a consensus rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is C$10.71.

Several research firms recently issued reports on VHI. TD Securities upgraded Vitalhub to a “strong-buy” rating in a research note on Monday, November 25th. Canaccord Genuity Group upped their price target on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research note on Thursday, January 16th. Finally, Scotiabank set a C$14.00 price target on shares of Vitalhub and gave the stock an “outperform” rating in a research report on Thursday.

Vitalhub Trading Down 3.5 %

Vitalhub stock opened at C$11.40 on Thursday. The company has a market capitalization of C$579.69 million, a price-to-earnings ratio of 103.64, a PEG ratio of 1.18 and a beta of 1.26. Vitalhub has a 12 month low of C$4.36 and a 12 month high of C$12.09. The stock’s 50 day moving average is C$11.30 and its 200-day moving average is C$9.71.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.